Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US11239427B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11239427-B2 |
| Application number | US-201716315485-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 6, 2017 |
| Priority date | Jul 6, 2016 |
| Publication date | Feb 1, 2022 |
| Grant date | Feb 1, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application provides a hetero-cyclic compound capable of significantly enhancing lifespan, efficiency, electrochemical stability and thermal stability of an organic light emitting device, and an organic light emitting device containing the hetero-cyclic compound in an organic compound layer.
Opening claim text (preview).
The invention claimed is: 1. A hetero-cyclic compound represented by the following Chemical Formula] 2 or 3: wherein, in Chemical Formula 2 and 3, at least one of R1 to R5 is represented by -(L2)p-(Z2)q and the rest are hydrogen; or deuterium, at least one of R12 to R16 is represented by -(L3)r-(Z3)s, and the rest are hydrogen; or deuterium, L2 and L3 are the same as or different from each other, and each independently a direct bond; or a substituted or unsubstituted C 6 to C 60 arylene group, Z2 and Z3 are the same as or different from each other, and each independently selected from the group consisting of a substituted or unsubstituted pyridine group; a substituted or unsubstituted pyrimidine group; a substituted or unsubstituted triazine group; a substituted or unsubstituted phenanthroline group; a substituted or unsubstituted quinoline group; a substituted or unsubstituted carbazole group; a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophene group; a substituted or unsubstituted anthracene group; a substituted or unsubstituted phenanthrene group; a substituted or unsubstituted biphenyl group; a substituted or unsubstituted naphthyl group; and —P(═O)RR′, p and r are an integer of 0 to 4; q and s are an integer of 1 to 4; R6 to R11 are hydrogen or deuterium; and R, and R′ are the same as or different from each other, and each independently hydrogen; deuterium; —CN; a substituted or unsubstituted C 1 to C 60 alkyl group; a substituted or unsubstituted C 3 to C 60 cycloalkyl group; a substituted or unsubstituted C 6 to C 60 aryl group; or a substituted or unsubstituted C 2 to C 60 heteroaryl group. 2. The hetero-cyclic compound of claim 1 , wherein Chemical Formula 2 or 3 is represented by any one of the following compounds:
comprising only nitrogen as heteroatom (H10K85/652 takes precedence) · CPC title
containing three or more hetero rings · CPC title
containing three or more hetero rings · CPC title
containing three or more hetero rings · CPC title
Aza-phenanthrenes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.